🇺🇸 FDA
Pipeline program

lorundrostat

MLS-101-901

Phase 3 small_molecule active

Quick answer

lorundrostat for Hypertension is a Phase 3 program (small_molecule) at Mineralys Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Mineralys Therapeutics
Indication
Hypertension
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials